Detalles de la búsqueda
1.
Changes in cell-free DNA after short-term palbociclib and fulvestrant treatment for advanced or metastatic hormone receptor-positive and human epidermal growth factor 2-negative breast cancer.
Breast Cancer Res Treat
; 203(2): 225-234, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37875670
2.
Fulvestrant plus palbociclib in advanced or metastatic hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer after fulvestrant monotherapy: Japan Breast Cancer Research Group-M07 (FUTURE trial).
Breast Cancer Res Treat
; 199(2): 253-263, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37000345
3.
Patient-reported outcome and quality of life research policy: Japan Clinical Oncology Group (JCOG) policy.
Jpn J Clin Oncol
; 53(3): 195-202, 2023 Mar 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36702740
4.
Switch maintenance endocrine therapy plus bevacizumab after bevacizumab plus paclitaxel in advanced or metastatic oestrogen receptor-positive, HER2-negative breast cancer (BOOSTER): a randomised, open-label, phase 2 trial.
Lancet Oncol
; 23(5): 636-649, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35405087
5.
Association of change in health-related quality of life and treatment discontinuation in metastatic breast cancer: a post hoc, exploratory analysis of two randomized clinical trials.
Support Care Cancer
; 30(10): 8367-8375, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35857127
6.
Association of Genetic Polymorphism with Taxane-induced Peripheral Neuropathy: Sub-analysis of a Randomized Phase II Study to Determine the Optimal Dose of 3-week Cycle Nab-Paclitaxel in Metastatic Breast Cancer Patients.
Acta Med Okayama
; 76(6): 661-671, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36549768
7.
Eribulin-based neoadjuvant chemotherapy for triple-negative breast cancer patients stratified by homologous recombination deficiency status: a multicenter randomized phase II clinical trial.
Breast Cancer Res Treat
; 188(1): 117-131, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33763789
8.
Secondary endpoints analysis in patients with estrogen receptor-positive metastatic breast cancer treated with everolimus and exemestane enrolled in Oral Care-BC.
BMC Cancer
; 21(1): 34, 2021 Jan 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33413212
9.
Oral Care Evaluation to Prevent Oral Mucositis in Estrogen Receptor-Positive Metastatic Breast Cancer Patients Treated with Everolimus (Oral Care-BC): A Randomized Controlled Phase III Trial.
Oncologist
; 25(2): e223-e230, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32043762
10.
Hormonal Therapy Resistant Estrogen-receptor Positive Metastatic Breast Cancer Cohort (HORSE-BC) Study : Current Status of Treatment Selection in Japan.
Acta Med Okayama
; 72(4): 369-374, 2018 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-30140084
11.
Cancer patient satisfaction with health care professional communication: An international EORTC study.
Psychooncology
; 31(3): 541-547, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34546631
12.
Evaluation of the effect of compression therapy using surgical gloves on nanoparticle albumin-bound paclitaxel-induced peripheral neuropathy: a phase II multicenter study by the Kamigata Breast Cancer Study Group.
Breast Cancer Res Treat
; 160(1): 61-67, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27620884
13.
Risk factors for joint symptoms in postmenopausal Japanese breast cancer patients treated with anastrozole: a prospective multicenter cohort study of patient-reported outcomes.
Int J Clin Oncol
; 21(2): 262-269, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26411314
14.
Appendiceal Metastasis of Breast Cancer: A Case Report and a Literature Review.
Cureus
; 16(4): e57929, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38725791
15.
Pilot trial of an electronic patient-reported outcome monitoring system in patients with metastatic breast cancer undergoing chemotherapy.
Breast Cancer
; 31(2): 283-294, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38175422
16.
Reliability and validity of the Japanese version of the Chemotherapy-induced Alopecia Distress Scale.
Breast Cancer
; 31(2): 234-242, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38079066
17.
Dramatic Recovery of Vision after Trastuzumab Deruxtecan Treatment of HER2-Positive Breast Cancer with Pituitary Metastasis.
Case Rep Oncol
; 16(1): 491-496, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37497420
18.
De-differentiation in cultures of organoids from luminal-type breast cancer is restored by inhibition of NOTCH signaling.
Hum Cell
; 36(6): 2099-2112, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37634223
19.
Development and validation of a symptom illustration scale from the patient-reported outcome common terminology criteria for adverse events for patients with breast cancer.
Breast Cancer
; 30(5): 856-868, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37422608
20.
The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2022 edition.
Breast Cancer
; 30(6): 872-884, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37804479